Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool read-only, idempotent, and non-destructive, and the description adds substantial behavioral detail beyond them: USPTO soft-fails after the API sunset, an empty FDA section is expected for non-biologic companies, and sources_used/sources_failed distinguish real no-data from bugs. This prevents an agent from misinterpreting legitimate empty results as failures.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but front-loaded with intent examples and the core selection rule before the detailed field-by-field breakdown. It is dense and occasionally runs on, but nearly every clause earns its place given the tool's eight-source complexity and nuanced failure semantics.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining return values, and it does so thoroughly: it enumerates the major result groups, their formats, the parallel fan-out across sources, and the sources_used/sources_failed signal. It also covers accepted input forms, private-company behavior, and expected empty sections, making the tool safely callable and interpretable.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3; the description adds meaningful resolver nuance not fully in the schema, such as names resolving via SEC EDGAR, resolved_from/resolved_to in the response, and type accepting 'company' or 'ticker' interchangeably. This supplements the schema rather than merely repeating it.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb-resource result: 'full cross-source profile of a US public company in ONE parallel call,' and opens with concrete user phrasings like 'Tell me about X' and 'research Acme.' The 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups' line clearly separates it from narrower tools, even though sibling research tools are not named.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says when to use it: ALWAYS PREFER this tool over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. It also clarifies accepted input shapes and the expected private-company fallback (resolved:false with notes), so an agent knows it is still the right call for a name that may not resolve.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

Many tools have overlapping purposes, such as ask_pipeworx, ask_pipeworx_grounded, deep_research, and also multiple Polymarket tools (bet_research, polymarket_edges, polymarket_arbitrage). Descriptions try to differentiate but the boundaries are unclear, causing confusion.

Naming Consistency2/5

Naming conventions are mixed: some use snake_case (ask_pipeworx, query_layer), some use descriptive phrases (entity_profile, recent_changes), and there is no consistent verb_noun pattern. The variety makes it hard to predict tool names.

Tool Count1/5

33 tools is far too many for a server named 'Arcgis Fairfield', as most tools are unrelated to GIS or Fairfield (e.g., npm dependency checks, prediction markets, AI visibility). The tool count severely mismatches the server's purported scope.

Completeness1/5

The server's stated purpose is ArcGIS Fairfield, but only 3 tools (layer_info, query_layer, search_datasets) relate to that domain. Critical GIS operations like updating features or managing services are missing, while the vast majority of tools are for other domains.